1,071
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Efficacy and safety of sotagliflozin in treating diabetes type 1

Pages 307-315 | Received 30 Jul 2017, Accepted 30 Nov 2017, Published online: 29 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shubham Batra, Prabhjeet Kaur Bamrah & Manjusha Choudhary. (2023) Sodium-glucose transporter (SGLT2) inhibition: A potential target for treatment of type-2 Diabetes Mellitus with Natural and Synthetic compounds. Egyptian Journal of Basic and Applied Sciences 10:1, pages 69-82.
Read now
Yoko Koike & Yasuo Terauchi. (2021) Are current SGLT2 Inhibitors efficacious treatment options for Type 1 diabetes?. Expert Opinion on Pharmacotherapy 22:9, pages 1079-1081.
Read now

Articles from other publishers (5)

Joanna Forycka, Joanna Hajdys, Julia Krzemińska, Piotr Wilczopolski, Magdalena Wronka, Ewelina Młynarska, Jacek Rysz & Beata Franczyk. (2022) New Insights into the Use of Empagliflozin—A Comprehensive Review. Biomedicines 10:12, pages 3294.
Crossref
Min Shi, Chao Wang, Jun Ji, Qu Cai, Qianfu Zhao, Wenqi Xi & Jun Zhang. (2022) CRISPR/Cas9-mediated knockout of SGLT1 inhibits proliferation and alters metabolism of gastric cancer cells. Cellular Signalling 90, pages 110192.
Crossref
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Subham Mahapatra, Daniel W. Carney, Erick A. Lindsey, Jacob C. DeForest, Scott P. France, Simon Berritt, Simone V. Bigi-Botterill, Tony S. Gibson, Yiyang Liu & Christopher J. O’Donnell. (2021) Synthetic Approaches to the New Drugs Approved during 2019. Journal of Medicinal Chemistry 64:7, pages 3604-3657.
Crossref
Lindsey Burggraaff, Paul Oranje, Robin Gouka, Pieter van der Pijl, Marian Geldof, Herman W. T. van Vlijmen, Adriaan P. IJzerman & Gerard J. P. van Westen. (2019) Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling. Journal of Cheminformatics 11:1.
Crossref
Kashif Haider, Ankita Pathak, Ankit Rohilla, Md Rafi Haider, Kamal Ahmad & M. Shahar Yar. (2019) Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. European Journal of Medicinal Chemistry 184, pages 111773.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.